Related Experiment Video
Updated: Jul 31, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for
Bishwajit Kundu1, Nilesh R Maiti, Eric M Jones
1Department of Physiology and Biophysics, Case Western Reserve University, 3109 Adelbert Road, Cleveland, OH 44106, USA.
Abstract:
One of the most intriguing disease-related mutations in human prion protein (PrP) is the Tyr to Stop codon substitution at position 145. This mutation results in a Gerstmann-Straussler-Scheinker-like disease with extensive PrP amyloid deposits in the brain. Here, we provide evidence for a spontaneous conversion of the recombinant polypeptide corresponding to the Y145Stop variant (huPrP23-144) from a monomeric unordered state to a fibrillar form. This conversion is characterized by a protein concentration-dependent lag phase and has characteristics of a nucleation-dependent polymerization. Atomic force microscopy shows that huPrP23-144 fibrils are characterized by an apparent periodicity along the long axis, with an average period of 20 nm. Fourier-transform infrared spectra indicate that the conversion is associated with formation of beta-sheet structure. However, the infrared bands for huPrP23-144 are quite different from those for a synthetic peptide PrP106-126, suggesting conformational non-equivalence of beta-structures in the disease-associated Y145Stop variant and a frequently used short model peptide. To identify the region that is critical for the self-seeded assembly of huPrP23-144 amyloid, experiments were performed by using the recombinant polypeptides corresponding to prion protein fragments 23-114, 23-124, 23-134, 23-137, 23-139, and 23-141. Importantly, none of the fragments ending before residue 139 showed a propensity for conformational conversion to amyloid fibrils, indicating that residues within the 138-141 region are essential for this conversion.
Insights
The Y145Stop mutation in human prion protein (PrP) causes disease. This study shows the Y145Stop PrP fragment spontaneously forms amyloid fibrils, with residues 138-141 being critical for this process.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- The Tyr to Stop codon mutation at position 145 (Y145Stop) in human prion protein (PrP) is linked to Gerstmann-Straussler-Scheinker-like disease.
- This mutation leads to extensive amyloid deposits in the brain, a hallmark of prion diseases.
Purpose of the Study:
- To investigate the spontaneous conversion of the Y145Stop PrP variant (huPrP23-144) into amyloid fibrils.
- To identify the specific region within huPrP23-144 essential for amyloid fibril formation.
Main Methods:
- Recombinant polypeptide expression and purification of huPrP23-144 and its fragments.
- Characterization of fibril formation using protein concentration-dependent assays, atomic force microscopy (AFM), and Fourier-transform infrared (FTIR) spectroscopy.
- Systematic deletion analysis of PrP fragments to pinpoint critical regions for amyloidogenesis.
Main Results:
- huPrP23-144 spontaneously converts from a disordered monomeric state to amyloid fibrils via nucleation-dependent polymerization.
- AFM revealed periodicity in fibrils, and FTIR confirmed the formation of beta-sheet structures, distinct from shorter model peptides.
- Residues 138-141 were identified as essential for huPrP23-144 self-seeded assembly into amyloid fibrils.
Conclusions:
- The Y145Stop PrP fragment possesses intrinsic properties enabling spontaneous amyloid formation.
- The 138-141 region of PrP is critical for the conformational conversion and self-assembly into amyloid fibrils associated with this disease mutation.
- Findings provide insights into the molecular mechanisms underlying prion protein misfolding and aggregation in disease.
Related Concept Videos
Protein Folding
Protein Folding
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Bacterial Protein Maturation

